Discovery of Highly Active Kynureninases for Cancer Immunotherapy through Protein Language Model
Discovery of Highly Active Kynureninases for Cancer Immunotherapy through Protein Language Model
About this item
Full title
Author / Creator
Publisher
Cold Spring Harbor: Cold Spring Harbor Laboratory Press
Journal title
Language
English
Formats
Publication information
Publisher
Cold Spring Harbor: Cold Spring Harbor Laboratory Press
Subjects
More information
Scope and Contents
Contents
Overcoming the immunosuppressive tumor microenvironment is a promising strategy in anticancer therapy. L-kynurenine, a strong immunosuppressive metabolite can be degraded through kynureninases. Through homology searches and protein language models, we identified and then experimentally determined the efficacy of four top-ranked kynureninases. The catalytically most active one nearly doubles turnover number over the prior best, reducing tumor weight by 3.42 times in mouse model comparisons, and thus, presenting substantial therapeutic potential.Competing Interest StatementM.S., W.J.S., J.Y., K.S.C., M.S.L., H.E., and Y-H.H. filed a provisional patent under the number PCT/KR2022/016093 related to our discovered KYUN K3.Footnotes* https://doi.org/10.5281/zenodo.10517668...
Alternative Titles
Full title
Discovery of Highly Active Kynureninases for Cancer Immunotherapy through Protein Language Model
Authors, Artists and Contributors
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_proquest_journals_2916735577
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_journals_2916735577
Other Identifiers
E-ISSN
2692-8205
DOI
10.1101/2024.01.16.575968
How to access this item
https://www.proquest.com/docview/2916735577?pq-origsite=primo&accountid=13902
